USD
$0.00
(0.00%
)At Close (As of Dec 11, 2025)
$1.01B
Market Cap
-
P/E Ratio
-0.94
EPS
$11.46
52 Week High
$1.07
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | -$31K |
| Total Revenue | $0 |
| Cost Of Revenue | $31K |
| Costof Goods And Services Sold | $31K |
| Operating Income | -$80M |
| Selling General And Administrative | $18M |
| Research And Development | $62M |
| Operating Expenses | $80M |
| Investment Income Net | - |
| Net Interest Income | $5.5M |
| Interest Income | $5.5M |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $31K |
| Income Before Tax | -$74M |
| Income Tax Expense | - |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$74M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$80M |
| Ebitda | -$80M |
| Net Income | -$74M |
| Field | Value (USD) |
|---|---|
| Gross Profit | -$31K |
| Total Revenue | $0 |
| Cost Of Revenue | $31K |
| Costof Goods And Services Sold | $31K |
| Operating Income | -$80M |
| Selling General And Administrative | $18M |
| Research And Development | $62M |
| Operating Expenses | $80M |
| Investment Income Net | - |
| Net Interest Income | $5.5M |
| Interest Income | $5.5M |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $31K |
| Income Before Tax | -$74M |
| Income Tax Expense | - |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$74M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$80M |
| Ebitda | -$80M |
| Net Income | -$74M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Rezolute, Inc. is a clinical-stage biopharmaceutical company headquartered in Redwood City, California, dedicated to developing innovative therapies for rare and metabolic diseases. The company boasts a promising pipeline targeting significant unmet medical needs, underpinned by its commitment to scientific advancement and clinical excellence. Through strategic collaborations and a focus on improving patient outcomes, Rezolute is uniquely positioned to make a substantial impact in the biopharmaceutical sector, aiming to transform the treatment landscape for underserved patient populations.